The Trump administration is pushing to fast-track psychedelic drug approvals as his economic approval ratings hit record lows, marking a sharp reversal from his first term stance on drugs. Three companies, Compass Pathways, Transcend Therapeutics and Usona Institute received priority FDA review vouchers under the executive order. Scientists and veterans are divided on whether the move is driven by a genuine commitment to mental health or political calculation.
Chapters:
00:00 - 01:17 Introduction
01:18 - 03:49 Chapter 1: Legitimizing a new wave of drugs
03:50 - 06:20 Chapter 2: Lead with science
06:21 - 09:44 Chapter 3: Political pressure
Reporting by: Brandon Gomez
Produced and Shot by: Ryan Baker
Edited by: Darren Geeter
Animation: Jason Reginato, Alisa Stern
Senior Director of Video: Lindsey Jacobson
Additional Footage: Getty Images, Healing Breakthrough, Marie Phelan, Juliana Mercer
» Subscribe to CNBC:
» Subscribe to CNBC TV:
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Want to get ahead at work? Then you need to learn how to make effective small talk. In CNBC’s new online course, How To Talk To People At Work, expert instructors teach you how to use everyday conversation to gain visibility, build meaningful relationships and advance your career. Sign up now:
Connect with CNBC News Onlin
|
Two controversial American left-wing inf...
CNBC's Leslie Picker has the latest on S...
Jean Eric Salata, the newly appointed ch...
Tyler Page, Cipher Digital CEO, joins 'P...
Printed circuit boards sit underneath ne...
Jean Eric Salata, the newly appointed ch...
Uber is cutting 23% of its people team, ...
Jean Eric Salata, the newly appointed ch...
GoldenTree Asset Management Founder and ...
SpaceX plans to offer shares at $135 api...
Bloomberg’s Caroline Hyde and Ed Ludlow ...
WIRED tasks Anna Faris, Marlon Wayans an...
There’s a land grab underway in the U.S....
Gabriel Zucman is the intellectual force...